Search

everythinglearnresearchcommunity

for

Search:↓

Progesterone increases alcohol tolerance and withdrawal anxiety, while DHEAS prevents them.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Special cells can help regrow hair in alopecia areata.

Alopecia areata patients experience more psychological distress, linked to certain neurotrophin levels.

Targeting specific metabolic and ionic pathways may improve alopecia areata treatment.

DPCP may be safe for treating alopecia during pregnancy, but more research is needed.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Targeting multiple pathways and understanding genetic mutations are crucial for effective melanoma therapy.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Upadacitinib effectively treats severe alopecia areata and is safe.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

A vibrating anesthetic device significantly reduces pain during mesotherapy for hair loss without complications.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

This therapy effectively treats resistant alopecia areata with minimal side effects.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

A new treatment plan helps manage folliculitis decalvans effectively.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Intramuscular triamcinolone acetonide is an effective treatment for severe alopecia areata, especially in males.

Fire needle therapy's benefits and safety for alopecia areata need more evidence.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.